X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (50) 50
humans (49) 49
hematology (38) 38
aged (34) 34
female (30) 30
male (29) 29
middle aged (27) 27
flow cytometry (24) 24
prognosis (24) 24
adult (22) 22
immunophenotyping (20) 20
oncology (19) 19
abridged index medicus (17) 17
aged, 80 and over (17) 17
minimal residual disease (16) 16
multiple myeloma - pathology (14) 14
phenotype (13) 13
flow cytometry - methods (12) 12
monoclonal gammopathy (12) 12
multiple myeloma - therapy (12) 12
hemic and lymphatic diseases (11) 11
multiple myeloma - mortality (11) 11
multiple-myeloma (11) 11
stem-cell transplantation (11) 11
undetermined significance (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
flow-cytometry (10) 10
multiple myeloma (10) 10
plasma cells - pathology (10) 10
survival (10) 10
therapy (10) 10
bone-marrow (9) 9
disease-free survival (9) 9
multiple myeloma - diagnosis (9) 9
multiple myeloma - drug therapy (9) 9
multiple myeloma - immunology (9) 9
diagnosis (8) 8
multiple myeloma - genetics (8) 8
plasma-cells (8) 8
survival rate (8) 8
time factors (8) 8
treatment outcome (8) 8
bortezomib (7) 7
criteria (7) 7
disease progression (7) 7
risk factors (7) 7
cancer (6) 6
chemotherapy (6) 6
expression (6) 6
follow-up studies (6) 6
kaplan-meier estimate (6) 6
neoplasm, residual (6) 6
remission induction (6) 6
transplantation (6) 6
bone marrow (5) 5
dexamethasone - administration & dosage (5) 5
genetic abnormalities (5) 5
induction (5) 5
mgus (5) 5
multiparameter flow-cytometry (5) 5
pathology (5) 5
plasma cells - immunology (5) 5
proportional hazards models (5) 5
prospective studies (5) 5
research (5) 5
risk assessment (5) 5
thalidomide - administration & dosage (5) 5
transplantation, autologous (5) 5
acute myeloid leukemia (4) 4
age factors (4) 4
analysis (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
apoptosis (4) 4
clone cells (4) 4
dexamethasone (4) 4
drug resistance, neoplasm (4) 4
drug-resistance (4) 4
elderly-patients (4) 4
gene expression regulation, neoplastic (4) 4
in situ hybridization, fluorescence (4) 4
induction chemotherapy (4) 4
lenalidomide (4) 4
leukemia, myeloid, acute - pathology (4) 4
multiple myeloma - metabolism (4) 4
paraproteinemias - pathology (4) 4
plasma cells (4) 4
polymerase-chain-reaction (4) 4
predictive value of tests (4) 4
prognostic value (4) 4
prognostic-factor (4) 4
progression (4) 4
usage (4) 4
adolescent (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biomarkers, tumor - metabolism (3) 3
body regions (3) 3
bone marrow cells - pathology (3) 3
boronic acids - administration & dosage (3) 3
care and treatment (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2017, Volume 35, Issue 25, pp. 2900 - 2910
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 12, pp. 1627 - 1633
Journal Article
Blood, ISSN 0006-4971, 06/2016, Volume 127, Issue 25, pp. 3165 - 3174
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 122, Issue 22, pp. 3591 - 3598
Journal Article
Blood, ISSN 0006-4971, 04/2016, Volume 127, Issue 15, pp. 1896 - 1906
Journal Article
Blood, ISSN 0006-4971, 04/2015, Volume 125, Issue 15, pp. 2370 - 2380
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 6, pp. 1166 - 1173
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 05/2019, Volume 33, Issue 5, pp. 1256 - 1267
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2016, Volume 34, Issue 15, pp. e18510 - e18510
Conference Proceeding
Haematologica, ISSN 0390-6078, 02/2011, Volume 96, Issue 2, pp. 328 - 332
Journal Article
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 09/2017, Volume 92, Issue 5, pp. 361 - 370
Journal Article